The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products

BACKGROUND: The National Institute for Health and Care Excellence (NICE) is responsible for ensuring that patients in England and Wales can access clinically and cost-effective treatments. However, NICE’s processes pose significant reimbursement challenges for treatments for rare diseases. While som...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dawn, McCarthy, Grant, Saeed, Omar, Allen, Rachel, Malottki, Kinga, Chandler, Fleur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043140/
https://www.ncbi.nlm.nih.gov/pubmed/36315388
http://dx.doi.org/10.1007/s41669-022-00378-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043140/
https://www.ncbi.nlm.nih.gov/pubmed/36315388
http://dx.doi.org/10.1007/s41669-022-00378-8

Ejemplares similares